Research/art/teacher profile of a person
Name and surname:
PharmDr. Mária Bodnár Mikulová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Bodnár Mikulová
I.2 - Name
Mária
I.3 - Degrees
PharmDr., PhD.
I.5 - Name of the workplace
Comenius University in Bratislava, Faculty of Pharmacy, Department of Pharmaceutical Analysis and Nuclear Pharmacy
I.6 - Address of the workplace
Odbojárov 10, 832 32 Bratislava 3, Slovakia
I.7 - Position
assistant professor
I.8 - E-mail address
mikulova43@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/25537
I.10 - Name of the study field in which a person works at the university
Pharmacy

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Pharmacy
II.c - Study field and programme
programme: Pharmacy; field: 7.3.1. Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Pharmacy
II.c - Study field and programme
programme: Pharmaceutical Chemistry; field: Pharmacy
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
assistant professor Comenius University in Bratislava, Faculty of Pharmacy from 06/2018

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
professional competence for the use of open and sealed radioactive sources Public Health Authority of the Slovak Republic 2019

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
4
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
16 (as a diploma thesis consultant), 6 (as a supervisor), 1 (rigorous thesis)
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Rádiofarmaká, FaF.KFANF/13-Mgr/20 Pharmacy 1st and 2nd Pharmacy
Radiopharmaceuticals, FaF.KFANF/13-Mgr-A/20 Pharmacy 1st and 2nd Pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
21
VI.1.b - Over the last six years
13
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
7
VI.1.b - Over the last six years
6
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
33
VI.1.b - Over the last six years
20
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
33
VI.1.b - Over the last six years
20
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Bodnár Mikulová M., et al. Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII. Int. J. Mol. Sci. [online]. Vol. 22, Is. 20 (2021), p. [1-19], art. no. 11283. ISSN 1422-0067.

2

Bodnár Mikulová M., Mikuš P. Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics. Pharmaceuticals [online]. Vol. 14, Is. 2 (2021), p. [1-40], art. no. 167. ISSN 1424-8247.

3

Mikuš P., et al. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX. Bioorg. Chem. [online]. 81 (2018), p. 241-252. ISSN 0045-2068.

VI.3 - The most significant research/artistic/other outputs over the last six years
1

see: http://alis.uniba.sk:9909/search/query?match_1=PHRASE&field_1=authid&term_1=1096682&sort=dateNewest&theme=EPC

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Mahboubi-Rabbani, M.; et al. Anti-Cancer Agents in Medicinal Chemistry, Vol. 21, Is. 16, 2021, s.2163-2180. SCOPUS/WOS;

Burmaoglu, S.; et al. Archives of Physiology and Biochemistry, Vol. 127, Is. 2, 2021, s.153-161. SCOPUS/WOS;

Gruner, B.; et al. Journal of Medicinal Chemistry, Vol. 62, Is. 21, 2019, s. 9560-9575. SCOPUS/WOS;

Achmad, A.; et al. Processes, Vol. 9, Is. 7, 2021, art. no. 1170. SCOPUS/WOS;

Havrankova, E.; et al. Bioorganic Chemistry, Vol. 107, 2021, art. no. 104565. SCOPUS/WOS;

Lolak, N.; et al. Bioorganic Chemistry, Vol. 100, 2020, art. no. 103897. SCOPUS/WOS;

for others see: http://alis.uniba.sk:9909/search/query?match_1=PHRASE&field_1=authid&term_1=1096682&sort=dateNewest&theme=EPC

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

leading of the Grant of the Scientific Board of the faculty No. GVRFaFUK/1/2023 (30 000 €)

participation in conducting the VEGA 1/0463/18 and KEGA 027UK-4/2020 projects as well as leading of 6 faculty/university grants

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
visit to a specialized clinic within the education from the course Radiopharmaceuticals Department of Nuclear Medicine, St.Elisabeth Oncology Institute in Bratislava from 2020
cooperation on laboratory practicals within the education from the course Radiopharmaceuticals BIONT, a.s., Bratislava from 2021

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542/2, 160 00 Praha 6, Czech Republic

IX. - Other relevant facts

Date of last update
2025-02-12